Pharmaceuticals

INVEST IN AFRICA NOW

Set-up your Business in Africa's Key Industrial Zones

Name *

Email *

Phone No. *

Tick if your WhatsApp number is same as the phone number

Investment Sector

Business Opportunity

How may we assist you?

*Note: Name, Email and Phone Number are mandatory.

I agree to the AFI privacy policy.*

I agree to receive e-communications from AFI.

THANK YOU

Our team will get back to you shortly.

There's growing demand for APIs to fuel local pharma industry in Nigeria, with government support for the industry and increased action from investors.

$20 Bn

Market Size

$1369 Mn

Import Value

Untapped Potential: Invest in API Pharma Industry of IPR, Nigeria

Nigeria's pharmaceutical sector is on the rise, but lags in domestic production of Active Pharmaceutical Ingredients (APIs), the backbone of medicines. Currently, there's 70% import reliance on medicines. This creates a lucrative opportunity for investors in Nigeria's IPR zones.

IPR zones offer investors a springboard into API Pharma manufacturing. Government incentives like tax breaks and infrastructure support, coupled with access to a large market and talent pool, make these zones an attractive proposition. Investors can capitalize on this potential by focusing on niche APIs, cost-effective production methods, or collaborating with research institutions. By overcoming challenges like attracting specialized talent and navigating global competition, investors in IPR zones can become pioneers in bolstering Nigeria's pharmaceutical industry and ensuring better healthcare access for its citizens.

Social Spotlight

Latest Insights